BioBots
Philadelphia, US · Founded 2014 · Delaware corporation
Biotech
Founders & leadership
DC
Daniel CabreraExecutive Officer, Director
RS
Ricardo SolorzanoExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements▶$1MraisedOct 2019 · 5 investors · BiotechnologyRule 506(b)
▶$1MraisedOct 2019 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Frank McCaneyDirector
- Madeline WinterExecutive Officer, Director
- Ricardo SolorzanoExecutive Officer, Director
- Evangeline GonzalezDirector
- Angelo MasciantonioDirector
- David JosephDirector
- Offering amount
- $2M
- Amount sold
- $1M
- Minimum investment
- $25K
- First sale
- Oct 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$30KraisedNov 2017 · 1 investors · BiotechnologyRule 506(b)
▶$30KraisedNov 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ricardo SolorzanoExecutive Officer, Director
- Madeline WinterExecutive Officer
- Offering amount
- $2M
- Amount sold
- $30K
- Minimum investment
- $25K
- Proceeds to insiders
- $3K
- First sale
- Nov 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$877KraisedAug 2015 · 8 investors · BiotechnologyRule 506(b)
▶$877KraisedAug 2015 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Daniel CabreraExecutive Officer, Director
- Ricardo SolorzanoExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $877K
- Minimum investment
- $25K
- Proceeds to insiders
- $120K
- First sale
- Jul 2015
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.